Last reviewed · How we verify

NCT04387591

Fu's Subcutaneous Needling Treatment for Biceps Tendinopathy

Completed NA Last updated 3 March 2021
What this trial tests

NA trial testing Fu's subcutaneous needling(FSN) in Bicep Tendinitis in 32 participants. Completed in 31 December 2020.

Timeline
20 May 2020
Primary endpoint
30 December 2020
31 December 2020

Quick facts

Lead sponsorChina Medical University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment32
Start date20 May 2020
Primary completion30 December 2020
Estimated completion31 December 2020
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

China Medical University Hospital

Who can join

20 and older, any sex, with Bicep Tendinitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Biceps tendinopathy is a common cause in shoulder-pain symptoms. The major mechanism is overuse of the biceps muscles. The long-term accumulated and poor repaired trauma causes myofascial trigger points in the related muscles.We will conduct the randomized, open label experiment to evaluate the immediate, short-term, and long-term effect of Fu's subcutaneous needling (FSN).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Fu's subcutaneous needling(FSN)

Trials testing the same drug.

Other China Medical University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04387591.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing